Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 77101-77150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05570812
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
PHASE2Recruiting
120 participants
Started: Mar 3, 2023 · Completed: Jan 31, 2028
3 conditions3 sponsors1 location
NCT05704881
Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
N/ARecruiting
240 participants
Started: Mar 3, 2023 · Completed: Dec 1, 2025
2 conditions2 sponsors2 locations
NCT05772364
High- Versus Low-calcium Water for Bone Health
NARecruiting
41 participants
Started: Mar 2, 2023 · Completed: May 31, 2026
5 conditions1 sponsor1 location
NCT05660161
This is a Study to Evaluate Nanofractures Technique in the Treatment of Cartilage Lesions
NARecruiting
20 participants
Started: Mar 2, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT04128189
Shingrix in Renal Transplant Recipients
PHASE3Recruiting
132 participants
Started: Mar 2, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05147649
Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome
NARecruiting
70 participants
Started: Mar 2, 2023 · Completed: Jul 2, 2026
1 condition1 sponsor1 location
NCT05548062
Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera
N/AActive, not recruiting
242 participants
Started: Mar 2, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor35 locations
NCT05477264
Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
PHASE2Recruiting
38 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05911464
A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors
PHASE1Recruiting
248 participants
Started: Mar 2, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05779345
Stability of Short Implants Versus Standard Blx Implants With Internal Sinus Floor Elevation in Posterior Maxilla
NARecruiting
42 participants
Started: Mar 2, 2023 · Completed: Jul 2, 2025
1 condition1 sponsor1 location
NCT05731037
Influence of Restitution Time in Treatment of Patellar Tendinopathy
NAActive, not recruiting
52 participants
Started: Mar 2, 2023 · Completed: Feb 1, 2027
2 conditions1 sponsor1 location
NCT05738005
Dietary Reporting in the Amyloidoses
NARecruiting
40 participants
Started: Mar 2, 2023 · Completed: Nov 21, 2025
1 condition1 sponsor1 location
NCT05450185
Filter Lifespan in Continuous Renal Replacement Therapy
N/ARecruiting
600 participants
Started: Mar 2, 2023 · Completed: Aug 31, 2025
3 conditions2 sponsors5 locations
NCT05947695
Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer
NARecruiting
100 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2029
2 conditions1 sponsor1 location
NCT05660382
Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis
PHASE3Recruiting
100 participants
Started: Mar 2, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor7 locations
NCT05645276
A Study of AK129 in Patients With Advanced Malignant Tumors
PHASE1Recruiting
182 participants
Started: Mar 2, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05618093
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH
NAEnrolling by invitation
100 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05489588
The GORE® VIAFORT Vascular Stent Iliofemoral Study
NARecruiting
165 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2031
10 conditions1 sponsor24 locations
NCT05785221
Lifestyle Intervention on Metabolic Homeostasis
NAActive, not recruiting
117 participants
Started: Mar 2, 2023 · Completed: Dec 1, 2025
4 conditions2 sponsors1 location
NCT05496829
IMPACT Trial: Intervention to iMProve AdherenCe Equitably
NARecruiting
350 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05386914
Short Term Sirolimus Treatment and MRI of the Brain and Lungs
PHASE1Recruiting
205 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05738434
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
PHASE2Recruiting
188 participants
Started: Mar 2, 2023 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT05493605
Cardiac Involvement in Wilson's Disease
NARecruiting
150 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06590506
High Definition Medicine for Solid Tumors Oncology
N/ARecruiting
300 participants
Started: Mar 2, 2023 · Completed: Jan 31, 2028
2 conditions1 sponsor9 locations
NCT05142787
Magseed Pro(R)/ Sentimag(R) Gen3
NARecruiting
224 participants
Started: Mar 2, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor6 locations
NCT05716282
Estimation of Neuromuscular Recovery - a Validation Study
N/ARecruiting
100 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06947915
Co-producing a Novel Model an Outcome Framework for the Implementation of Falls Management in Care Home Settings.
N/ARecruiting
31 participants
Started: Mar 2, 2023 · Completed: Jun 30, 2025
3 conditions2 sponsors1 location
NCT05284955
Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (SAINTS B)
PHASE4Recruiting
60 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT05860374
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
EARLY_PHASE1Recruiting
20 participants
Started: Mar 2, 2023 · Completed: Mar 2, 2026
9 conditions2 sponsors1 location
NCT05696015
Impact of Telehealth Education in Diabetes Patients
NANot yet recruiting
200 participants
Started: Mar 2, 2023 · Completed: Dec 30, 2025
2 conditions1 sponsor0 locations
NCT06462703
Tablet-based Application for Cognitive Therapy
NARecruiting
200 participants
Started: Mar 2, 2023 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05741957
Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease
NARecruiting
300 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05682391
Bed Rest on the Effect of CSF Leakage Repair After Transsphenoidal Pituitary Surgery
NAEnrolling by invitation
180 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05747079
Immediate Versus Optional Delayed Surgical Repair for Treatment of Acute ACL Injuries
NARecruiting
280 participants
Started: Mar 2, 2023 · Completed: Mar 2, 2028
1 condition6 sponsors1 location
NCT05209854
Evaluation of Therapeutic Management in Chronic Low Back Pain Patients
N/ARecruiting
613 participants
Started: Mar 2, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05326334
THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)
N/ARecruiting
20 participants
Started: Mar 2, 2023 · Completed: Sep 30, 2029
1 condition1 sponsor1 location
NCT05910710
Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
N/ARecruiting
50 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04776993
A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy
PHASE3Recruiting
52 participants
Started: Mar 2, 2023 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05668403
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
PHASE1Recruiting
52 participants
Started: Mar 2, 2023 · Completed: Dec 30, 2027
1 condition2 sponsors6 locations
NCT06440083
Pre-warning Risk Scoring System for Sudden Cardiac Death
N/ARecruiting
100,000 participants
Started: Mar 2, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06090656
Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)
PHASE2Recruiting
88 participants
Started: Mar 2, 2023 · Completed: Jul 25, 2025
1 condition1 sponsor1 location
NCT05958719
Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma
PHASE2Recruiting
37 participants
Started: Mar 2, 2023 · Completed: Mar 2, 2027
2 conditions1 sponsor1 location
NCT05698329
Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
PHASE1Active, not recruiting
19 participants
Started: Mar 2, 2023 · Completed: Apr 1, 2025
3 conditions1 sponsor6 locations
NCT05746871
Safety and Performance of Agilik in CP
NARecruiting
20 participants
Started: Mar 2, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05812040
Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge
NARecruiting
88 participants
Started: Mar 2, 2023 · Completed: May 30, 2024
2 conditions1 sponsor1 location
NCT05639114
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
PHASE3Recruiting
406 participants
Started: Mar 2, 2023 · Completed: Apr 20, 2029
1 condition1 sponsor187 locations
NCT06478030
Combined Screening for Gastrointestinal Tumors
N/ARecruiting
200,000 participants
Started: Mar 1, 2023 · Completed: Dec 31, 2028
1 condition6 sponsors2 locations
NCT05752890
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma
N/ANot yet recruiting
95 participants
Started: Mar 1, 2023 · Completed: Jan 31, 2031
4 conditions1 sponsor0 locations
NCT05728541
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
PHASE1Not yet recruiting
367 participants
Started: Mar 1, 2023 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05469997
Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome
NAActive, not recruiting
50 participants
Started: Mar 1, 2023 · Completed: Jul 31, 2025
1 condition2 sponsors1 location